NCT06432296 2026-05-11Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific AntibodyWuhan YZY Biopharma Co., Ltd.Phase 3 Active not recruiting312 enrolled